Janus Henderson Investors US’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
Janus Henderson Investors US's AGN Position: Q1 2017 in Review
Janus Henderson Investors US reduced its Allergan plc (AGN) stake by 2.8% in Q1 2017, selling an estimated $25.6M and leaving 3,787,948 shares worth $905M. The position accounts for 0.74% of the portfolio, ranked #16.
Janus Henderson Investors US first reported a position in AGN in Q2 2013 and has held it in 16 quarters since. The position peaked at $1.85B in Q2 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.
- Janus Henderson Investors US held 3,787,948 shares of Allergan plc worth $905M as of Q1 2017.
- Janus Henderson Investors US sold 109,925 Allergan plc shares in Q1 2017, an estimated $25.6M.
- Allergan plc made up 0.74% of Janus Henderson Investors US's portfolio in Q1 2017, its #16 holding.
- Janus Henderson Investors US first reported a position in Allergan plc in Q2 2013 and has held it in 16 quarters since.
- Janus Henderson Investors US's Allergan plc position peaked at $1.85B in Q2 2015.
- 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.
Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.